Back to marketplace

Exam 3 Tumor Markers

No description yet. This curated deck is ready for daily study.

Total cards: 24•Content version: v4•Public deck•Updated: 8/1/2026

Card preview (24)

#1
Front (Question)

Functions of tumor marker testing

Back (Answer)

• Detect and monitor cancer or effectiveness of treatment • Markers are produced by tumor directly or as an effect of tumor on healthy tissue • Concentration increases with tumor progression, highest levels when tumors metastasize

#2
Front (Question)

Types of tumor markers

Back (Answer)

• Enzymes • Serum proteins • Hormones & metabolites • Oncofetal antigens • Receptors

#3
Front (Question)

Characteristics of enzyme tumor markers

Back (Answer)

• Levels of certain enzymes correlate with tumor burden

#4
Front (Question)

Examples of enzyme tumor markers

Back (Answer)

• ALP: bone, liver, intestine • Amylase: pancreas • LD: liver, lymphomas • ACP: prostate

#5
Front (Question)

Example of serum protein tumor markers

Back (Answer)

Multiple myeloma light chains found in urine

#6
Front (Question)

Examples of hormone tumor markers

Back (Answer)

• ACTH: pituitary adenoma and ectopic lung tumor • HCG: testicular tumor • ADH: lung carcinoma • Catecholamines: neuroblastoma

#7
Front (Question)

Examples of oncofetal tumor makers

Back (Answer)

• Carcinoembryonic antigen (CEA) – colorectal * Alpha-fetoprotein (AFP) – hepatocellular or testicular

#8
Front (Question)

Examples of receptor tumor markers

Back (Answer)

• ERA – estrogen receptor assay • PRA – progesterone receptor assay - Presence indicates that tumor will likely respond to treatment

#9
Front (Question)

Applications of tumor markers

Back (Answer)

• Screening populations at risk • Diagnosis • Prognosis • Monitoring response to treatment • Detection of recurrence

#10
Front (Question)

Lab considerations for tumor marker testing

Back (Answer)

• Standardization between test methods or instruments is not as good as for other common assays • Comparisons from two different assays can be dangerous due to differences in: o Antibody specificity o Assay design and diversity o Lack of standard reference material o Variation in reference ranges • Example: variation in PSA results from two different assays o Testing done on “access” was consistently higher (1.23x) than testing done on “centaur”

#11
Front (Question)

Tumor marker methodology

Back (Answer)

• Immunoassay - most common • Advantage: ability to automate testing • May show the hook effect

#12
Front (Question)

AFP tumor marker for:

Back (Answer)

Hepatocellular or testicular cancer

#13
Front (Question)

CA-125 tumor marker for:

Back (Answer)

Ovarian tumors

#14
Front (Question)

CEA tumor marker for:

Back (Answer)

Colorectal cancer - > 10 suggestive of disease, > 20 assume metastasis

#15
Front (Question)

hCG tumor marker for:

Back (Answer)

Testicular cancer

#16
Front (Question)

PSA tumor marker for:

Back (Answer)

prostate cancer • can be elevated in infection, irritate, benign prostate enlargement • pts with prostate cancer have a lower % of free PSA

#17
Front (Question)

PSA range

Back (Answer)

< 4ng/mL

#18
Front (Question)

CA 15-3 tumor marker for:

Back (Answer)

metastatic breast cancer

#19
Front (Question)

CA 27-29 tumor marker for:

Back (Answer)

elevated in recurrent breast cancer

#20
Front (Question)

BRCA1 & BRCA2 tumor markers

Back (Answer)

hereditary breast-ovarian tumor syndrome

#21
Front (Question)

Describe stage I cancer

Back (Answer)

localized primary tumor

#22
Front (Question)

Describe stage II cancer

Back (Answer)

invasion of primary tumor through epithelium and into blood vessels

#23
Front (Question)

Describe stage III cancer

Back (Answer)

migration of tumor into regional lymph nodes

#24
Front (Question)

Describe stage IV cancer

Back (Answer)

metastasis and invasion of tumor to distant tissues